Company · CIK 0001093557 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
DEXCOM INC · DXCM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 4:25 pm EDT | Michael Jon BrownEVP Chief Legal Compliance Off | 1,700 | $84.04 | $142,868 | 99,885 | −1.67% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 4:26 pm EDT | Nicholas AugustinosDirector | 8,089 | $84.04 | $679,769 | 29,293 | −21.6% | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 14, 4:02 pm EDT | Jereme M SylvainEVP, Chief Financal Officer | 3,638 | $83.27 | $302,936 | 146,828 | −2.42% | 10b5-1 |
| Sep 10, 2026 AForm 4 → | Sep 10, 4:40 pm EDT | Glenn S BoehnleinDirector | 5,841 | — | — | 5,841 | — | |
| Aug 27, 2026 SForm 4 → | Aug 28, 4:57 pm EDT | Sadie SternEVP Chief People & Culture Off | 2,565 | $88.37 | $226,669 | 126,043 | −1.99% | 10b5-1 |
| Aug 22, 2026 FForm 4 → | Aug 25, 4:14 pm EDT | Jacob Steven LeachPresident, CEO, and Director, Director | 1,451 | $92.34 | $133,985 | 418,908 | — | |
| Aug 22, 2026 FForm 4 → | Aug 25, 4:14 pm EDT | Jereme M SylvainEVP, Chief Financal Officer | 1,451 | $92.34 | $133,985 | 150,390 | — | |
| Aug 22, 2026 FForm 4 → | Aug 25, 4:14 pm EDT | Michael Jon BrownEVP Chief Legal Compliance Off | 1,451 | $92.34 | $133,985 | 101,502 | — | |
| Aug 22, 2026 FForm 4 → | Aug 25, 4:14 pm EDT | Sadie SternEVP Chief People & Culture Off | 1,451 | $92.34 | $133,985 | 128,608 | — | |
| Aug 20, 2026 SForm 4 → | Aug 24, 4:01 pm EDT | Kevin R SayerExecutive Chair, Director | 26,756 | $90.01 | $2,408,242 | 302,214 | −8.13% | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 17, 4:08 pm EDT | Michael Jon BrownEVP Chief Legal Compliance Off | 1,700 | $91.93 | $156,281 | 102,953 | −1.62% | 10b5-1 |
| Aug 12, 2026 GForm 4 → | Aug 13, 6:38 pm EDT | Nicholas AugustinosDirector | 1,075 | — | — | 37,382 | — | |
| Aug 12, 2026 SForm 4 → | Aug 13, 4:04 pm EDT | Bridgette P HellerDirector | 1,012 | $88.29 | $89,349 | 29,570 | −3.31% | 10b5-1 |
| Jul 31, 2026 SForm 4 → | Aug 4, 4:38 pm EDT | Mark G FolettaDirector | 4,000 | $82.66 | $330,640 | 48,852 | −7.57% | 10b5-1 |
| Jul 20, 2026 SForm 4 → | Jul 21, 4:58 pm EDT | Kevin R SayerExecutive Chair, Director | 26,756 | $76.32 | $2,041,999 | 328,970 | −7.52% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 5:06 pm EDT | Michael Jon BrownEVP Chief Legal Compliance Off | 1,700 | $74.42 | $126,514 | 104,653 | −1.60% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 7, 4:09 pm EDT | Kevin R SayerExecutive Chair, Director | 26,756 | $72.00 | $1,926,432 | 355,726 | −7.00% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 4:32 pm EDT | Michael Jon BrownEVP Chief Legal Compliance Off | 1,700 | $75.55 | $128,435 | 106,353 | −1.57% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 4:32 pm EDT | Mark G FolettaDirector | 4,000 | $74.13 | $296,540 | 52,852 | −7.04% | 10b5-1 |
| Jun 3, 2026 SForm 4 → | Jun 5, 4:17 pm EDT | Jon ColemanEVP, Chief Commercial Officer | 9,823 | $73.56 | $722,628 | 95,450 | −9.33% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.